Studies Are Validating Medical Marijuana Inc (OTCMKTS:MJNA) RSHO-X Nutraceutical Brand, and Shares Could Rise


Medical Marijuana Inc (OTCMKTS:MJNA) had some developments, recently, that could be indications that the stock could run higher. Now, if you’ve been following us, you may or may not remember we noted that MJNA shares could rise from its recent product unveiling. That in mind, there were some new studies that indicate the effectiveness of its hemp-derived CBD oil. In turn, this may cause the stock to run higher.


Now, CFN Media Group, one of the world’s leading creative agencies and digital media networks dedicated to legal cannabis, recently announced its publication of an article discussing recent studies , which demonstrated the effectiveness of Medical Marijuana Inc.’s RSHO-X brand of hemp-derived cannabidiol (CBD) oil.


The Por Grace Foundation, based in Mexico, recently released news of a new survey of Mexican parents of children with refractory epilepsy. Now, the more than 40 family survey found that over 80% of children experienced a reduction in convulsions following the use of CBD oil and more than 70% of the families used the Medical Marijuana Inc (OTCMKTS:MJNA) RSHO-X brand to treat the condition. The company’s RSHO-X product is currently the only legal option for parents looking to import CBD oil to Mexico, with approval from COFEPRIS, the country’s healthcare arm.


That in mind, Medical Marijuana is tapping into the Mexican legal cannabis market with the product, and could continue to grow its market share in the space. That means higher potential profits and revenues for the company, and in turn, this could cause its share price to rise.

The In a survey which recently used Medical Marijuana subsidiary HempMeds Mexico’s flagship product, Real Scientific Hemp Oil-X (RSHO-X). Keep in mind, RSHO-X was the first product to receive COFEPRIS approval for import into Mexico and is 100% THC-free. With that said, this caters to patients who would like the benefits of medicinal marijuana, without the psychoactive effects. That said, it’s well-positioned in a niche market, which could help the company grow its earnings,significantly.


In the survey, which was the first observational study that was carried out in Mexico and explored the use of medicinal cannabis in pediatric RE, it noted that out of the 43 cases, over 50% showed a significant decrease in convulsions, which was over a 75% reduction. Moreover, over 15% of those cases were reported as completely seizure free.


The independent study also noted that were was an overall increased quality of life of the patients, with nearly 90% of patients showed improved cognition, over 80% showed improved emotions or mood, and nearly 80% showed an improvement in sleep, and nearly 70% showed a better appetite. Consequently, this may prove the efficacy of Medical Marijuana’s product.


According to Raul Elizalde, President of the Por Grace Foundation, “These new survey findings where the improvements reported by the parents were related not only to the frequency of the seizures, but also their duration and intensity, come on the heels of another critical study recently performed in Mexico with our Company’s RSHO-X product, which also showcased the therapeutic benefits of hemp-based botanical CBD…We are excited that new evidence on how CBD oil is providing epileptic children with relief continues to emerge in Mexico and we expect this news to spread and help patients all across the world.”
Now that you are caught up with some of MJNA’s recent news, you may realize the growth potential in the stock. However, you would want to hear about these developments earlier, rather than later because opportunities may dry up. To stay on top of MJNA’s news, all you have to do is subscribe to our 100% free newsletter by providing us with your email address in the box below. After that, we’ll send you updates on MJNA, if any.